McDermott + Bull Partner Ken Dropiewski interviews CRG Director Sabir Rassiwalla in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Sabir discuss MedTech’s continuously changing landscape, what makes CRG different from other healthcare investors, and what to expect to see from the firm in the future.
Investor Insights: Ken Dropiewski with Sabir Rassiwalla of CRG
